Drug developers continue to face increasingly complex formulation and delivery challenges as pipelines expand beyond traditional small molecules to include biologics, peptides, nucleic acids, antibody-drug conjugates, and other advanced therapeutics. Success depends on identifying technologies that improve solubility, stability, bioavailability, targeting, and patient outcomes while navigating evolving regulatory and development requirements.
To help address these challenges, Ascendia Pharmaceutical Solutions will host its 4th annual 2- day workshop entitled Advances in Innovative Technologies for Formulation and Delivery of Molecules Across All Modalities - on September 15–16, 2026, at the Crowne Plaza Princeton Conference Center in Plainsboro Township, New Jersey.
This two-day event will bring together pharmaceutical industry leaders, academic researchers, regulatory scientists, formulation experts, and professors and students from academia to explore the latest advances in drug delivery and formulation technologies. Through scientific presentations and collaborative discussions, the attendees will gain practical insights into approaches shaping the future of pharmaceutical development.
Click here to register for the workshop!
This workshop is designed to foster scientific exchange across multiple therapeutic modalities and routes of administration. Discussions will focus on strategies for improving the performance of molecules delivered through oral, parenteral, ocular, nasal, and inhalation routes.
Attendees will have the opportunity to engage with experts working at the forefront of pharmaceutical innovation and gain a deeper understanding of technologies that are advancing drug development programs from discovery through clinical stages and commercialization.
The workshop will feature presentations from leading scientists representing global pharmaceutical companies, academic institutions, regulatory organizations, and research centers.
Featured keynote speakers include Robert Langer, ScD, Institute Professor at the Massachusetts Institute of Technology, and Kinam Park, PhD, Distinguished Professor at Purdue University. Innovators of several startups and biotechs, their contributions to drug delivery science have influenced the development of numerous technologies that continue to impact modern pharmaceutical research and development.
Additional speakers will represent organizations including AstraZeneca, Novo Nordisk, Eli Lilly and Company, Pfizer, -, Abbvie, Merck & Co., Shionogi, -, the University of Pennsylvania, the University of Connecticut, Brown University, the University of Delaware, Georgia Institute of Technology, the University of Colorado, St. John's University, and Ascendia Pharmaceutical Solutions.
The workshop agenda addresses a broad range of formulation and delivery technologies relevant to current and future drug development programs.
Sessions will examine innovative nanotechnologies designed to address unmet medical needs and the expanding role of nanoparticles in oncology and inflammatory diseases. Discussions will explore how macrophage interactions influence therapeutic performance and how antibody-drug conjugated lipid nanoparticles can improve targeting of tumor cells.
Attendees will also gain insights into excipient selection strategies for peptide and GLP-1 delivery, advances in long-acting injectables, and the development of high-concentration nanosuspensions for controlled-release applications.
Additional presentations will cover lipid nanoparticle technologies for oral, nasal, and inhalation delivery, ophthalmic nanotechnology applications, and the use of lipid nanoparticles for delivering mRNA, biologics, and other macromolecules.
The program will also address amorphous solid dispersion development, hydrophobic ion pairing approaches for improving solubility and in vivo efficacy, and advanced modeling and multivariate data analysis techniques that support drug product development.
Beyond the scientific content, the workshop provides an environment for collaboration between pharmaceutical companies, academic institutions, regulatory organizations, and emerging researchers.
Attendees will have opportunities to exchange ideas, discuss current development challenges, evaluate emerging technologies, and establish relationships that can support future innovation. The workshop's multidisciplinary approach encourages dialogue across scientific specialties and therapeutic modalities, creating opportunities for meaningful collaboration.
The workshop is intended for formulation scientists, analytical scientists, pharmaceutical researchers, regulatory professionals, and industry consultants involved in drug development and delivery technologies.
It is also well-suited for managers, vice presidents, chief scientific officers, chief executive officers, and academic researchers seeking to stay informed about emerging formulation strategies and drug delivery innovations. University students interested in nanotechnology, solubilization sciences, and advanced drug delivery systems will also benefit from attending.
The pharmaceutical industry continues to evolve as new therapeutic modalities create new formulation and delivery challenges. Scientific collaboration and knowledge sharing remain essential for translating promising molecules into successful therapies.
The Advances in Innovative Technologies for Formulation and Delivery of Molecules Across All Modalities workshop provides a unique opportunity to learn directly from leading experts, explore emerging technologies, and connect with professionals working across the pharmaceutical development landscape.